Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nanotechnology in proteomics.

Nicholas F Marko1, Robert J Weil, Steven A Toms

  • 1Cleveland Clinic Foundation, Department of Neurosurgery, 9500 Euclid Avenue, Cleveland, OH, USA. markon@ccf.org

Expert Review of Proteomics
|October 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single cell and spatial sequencing analysis of cancer associated fibroblasts in the brain metastasis tumor microenvironment.

Communications biology·2026
Same author

A neurosurgical reappraisal of President Lincoln's fatal cranial injury.

Neurosurgical review·2025
Same author

Applying brain injury guidelines to patients with traumatic brain injury: A contemporary, consecutive series.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2025
Same author

Tumor-Associated Tractography Derived from High-Angular-Resolution Q-Space MRI May Predict Patterns of Cellular Invasion in Glioblastoma.

Cancers·2024
Same author

Social determinants of health and outcome disparities in spine tumor surgery. Part 2: Neighborhood disadvantage and long-term outcomes.

Journal of neurosurgery. Spine·2024
Same author

Social determinants of health and outcome disparities in spine tumor surgery. Part 1: An analysis of 6.6 million nationwide admissions.

Journal of neurosurgery. Spine·2024
Same journal

Unveiling the post translational modification code in Alzheimer's pathogenesis: crosstalk between phosphorylation and acetylation.

Expert review of proteomics·2026
Same journal

Plasma proteome profiles of standard-risk and high-risk childhood acute lymphoblastic leukemia.

Expert review of proteomics·2026
Same journal

Potential proteomic biomarkers for monitoring clinical studies in Duchenne/Becker muscular dystrophy.

Expert review of proteomics·2026
Same journal

Proteomics-based approaches to neutrophil biology.

Expert review of proteomics·2026
Same journal

Deciphering mitochondrial metabolic vulnerabilities in ovarian clear cell carcinoma with mass spectrometry-based clinical proteomics.

Expert review of proteomics·2026
Same journal

The proteomic origin of the genetic code.

Expert review of proteomics·2026
See all related articles

Nanotechnology enables sensitive detection of low-abundance proteins, advancing proteomics for human disease research. This breakthrough allows for more complex analysis, similar to genomics, by improving signal detection and multiplexing capabilities.

Area of Science:

  • Proteomics
  • Genomics
  • Nanotechnology
  • Biomedical Applications

Background:

  • Genomics advances in understanding gene expression in human disease contrast with proteomics' limitations in detecting rare proteins.
  • The inability to amplify and detect low-abundance proteins has hindered complex proteomic analyses compared to genomic studies.

Purpose of the Study:

  • To review nanotechnology-based techniques for identifying low-abundance proteins.
  • To highlight the implementation of these techniques in current protein research.
  • To comment on their future role in proteomic investigations and biomedical applications.

Main Methods:

  • Nanoparticle and nanoscale device-based techniques for protein detection.
  • Methods enabling enhanced multiplexing and improved signal-to-noise ratios.

Related Experiment Videos

  • Specific techniques include nanowires, nanocantilevers, bio-barcoding, and surface-enhanced Raman spectroscopy.

    • Main Results:

    • Current technology allows for significant enhancement in detecting low-abundance proteins in cellular and tissue lysates.
    • Techniques can detect proteins in the low attomolar range, crucial for studying cellular processes.
    • Advances improve signal-to-noise ratios and enable more effective multiplexing.

    Conclusions:

    • Nanotechnology offers powerful tools to overcome previous limitations in low-abundance protein detection.
    • These advancements are crucial for dissecting human disease complexity through proteomics.
    • Future proteomic research and biomedical applications will benefit significantly from these emerging techniques.